Skip to main content

Patient Reported Pain Interference Following Chemotherapy among Adults with Breast Cancer

CBE ID
3718
Endorsed
Endorsement Status
Endorsed
1.1 New or Maintenance
New
E&M Cycle
Fall 2022
Is Under Review
No
Next Planned Maintenance Review
Fall 2027
E&M Cycle Comments

Effective March 27, 2023, the National Quality Forum (NQF) is no longer the consensus-based entity (CBE) funded through the Centers for Medicare & Medicaid Services (CMS) National Consensus Development and Strategic Planning for Health Care Quality Measurement Contract. Battelle has been selected to oversee the endorsement & maintenance (E&M) of clinical quality and cost/resource use measures. Since the Fall 2022 cycle launched at NQF, measures submitted to this E&M cycle continued along the prior E&M protocols that were in place at time of the Fall 2022 “Intent to Submit.” Battelle took over the E&M work for the Fall 2022 cycle after developers and/or stewards submitted their full measure information to NQF, which for CBE #3718, the most recent measure specifications can be found here: https://p4qm.org/sites/default/files/2024-02/3718.zip

Battelle took over the E&M work beginning with the public comment period to close the E&M committees for the post-comment meeting, convening the CSAC to render a final endorsement decision, and executing the appeals period.

 

1.3 Measure Description
The PRO-PM assesses pain interference among adult women with breast cancer entering survivorship after completion of chemotherapy administered with curative intent. Pain interference is assessed using the PROMIS Pain Interference 4a scale administered at baseline (prior to chemotherapy) and at follow-up (about three months following completion of chemotherapy). The measure is risk-adjusted.
    • 1.14 Numerator

      The PRO-PM numerator is the group-level PROMIS Pain Interference score at the follow-up survey.

    • 1.15 Denominator

      Adult patients with stages I-III female breast cancer receiving an initial chemotherapy regimen within the measurement window.

    • 1.13a Data dictionary not attached
      No
      OLD 1.12 MAT output not attached
      Attached
    • Most Recent Endorsement Activity
      Endorsed Patient Experience and Function Fall 2022
      Initial Endorsement
      Last Updated
    • Risk adjustment approach
      Off
      Risk adjustment approach
      Off
      Conceptual model for risk adjustment
      Off
      Conceptual model for risk adjustment
      Off